Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Peptic Ulcer

Free Subscription Articles published in Gut Retrieve available abstracts of 35 articles: HTML format

Single Articles

January 2026
1. COLLATUZZO G, Camargo MC, Malvezzi M, Dajti E, et al
   Gastric cancer attributable to Helicobacter pylori in 2040.
   Gut. 2026 Jan 28:gutjnl-2025-337499. doi: 10.1136/gutjnl-2025-337499.
   PubMed    
   
   
   
2. ZHENG B, Kobayashi H, Tu R, Huang K, et al
   Gastrin-dependent expansion of Cck2r(+) corpus progenitors accelerates ulcer healing and inhibits gastric dysplasia.
   Gut. 2026;75:265-277.
   PubMed     Abstract available
   
   
   December 2025
3. NOH Y, Choi A, Lee H, Yon DK, et al
   Proton pump inhibitors use and risk of inflammatory bowel disease in children.
   Gut. 2025 Dec 31:gutjnl-2025-337345. doi: 10.1136/gutjnl-2025-337345.
   PubMed    
   
   
   November 2025
4. NIGAM GB, Oakland K, Hearnshaw S, Grasnt-Casey J, et al
   Acute upper gastrointestinal bleeding in the UK: 2022 audit update.
   Gut. 2025 Nov 19:gutjnl-2025-335134. doi: 10.1136/gutjnl-2025-335134.
   PubMed     Abstract available
   
   
   
5. WANG Y, Lu C, Liang Z, Weng D, et al
   Does the benefit of haemostatic powder differ by Forrest classification in non-variceal upper gastrointestinal bleeding?
   Gut. 2025 Nov 17:gutjnl-2025-337421. doi: 10.1136/gutjnl-2025-337421.
   PubMed    
   
   
   October 2025
6. LEUNG WK, Ang TL, Shah S, Cheung KS, et al
   Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions.
   Gut. 2025 Oct 7:gutjnl-2025-335823. doi: 10.1136/gutjnl-2025-335823.
   PubMed     Abstract available
   
   
   September 2025
7. LIOU JM, Malfertheiner P, Hong TC, Cheng HC, et al
   Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.
   Gut. 2025 Sep 5:gutjnl-2025-336027. doi: 10.1136/gutjnl-2025-336027.
   PubMed     Abstract available
   
   
   July 2025
8. SCHULZ C, Liou JM, Alboraie M, Bornschein J, et al
   Helicobacter pylori antibiotic resistance: a global challenge in search of solutions.
   Gut. 2025 Jul 11:gutjnl-2025-335523. doi: 10.1136/gutjnl-2025-335523.
   PubMed     Abstract available
   
   
   June 2025
9. GONG R, Huang B, Ralser A, Friedrich V, et al
   CagA-dependent Hobit(+) gastric tissue-resident memory T cells confer full protection from Helicobacter pylori reinfection.
   Gut. 2025 Jun 5:gutjnl-2025-334781. doi: 10.1136/gutjnl-2025-334781.
   PubMed     Abstract available
   
   
   May 2025
10. SHIN J, Cha B, Hong J, Kwon KS, et al
    Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial.
    Gut. 2025 May 13:gutjnl-2024-332459. doi: 10.1136/gutjnl-2024-332459.
    PubMed     Abstract available
    
    
    April 2025
11. LEE YC
    Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication.
    Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329.
    PubMed    
    
    
    October 2024
12. OLMEDO L, Calvet X, Gene E, Bordin DS, et al
    Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
    Gut. 2024 Oct 26:gutjnl-2024-332804. doi: 10.1136/gutjnl-2024-332804.
    PubMed     Abstract available
    
    
    August 2024
13. LIU Z, Hong J, He F
    Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2024 Aug 29:gutjnl-2024-333604. doi: 10.1136/gutjnl-2024-333604.
    PubMed    
    
    
    July 2024
14. ZHANG Q, Dunbar KB, Odze RD, Agoston AT, et al
    Hypoxia-inducible factor-1alpha mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.
    Gut. 2024;73:1269-1279.
    PubMed     Abstract available
    
    
    June 2024
15. GAO W, Liu J, Wang X, Li J, et al
    Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy.
    Gut. 2024 Jun 21:gutjnl-2024-332640. doi: 10.1136/gutjnl-2024-332640.
    PubMed     Abstract available
    
    
    May 2024
16. YUAN S, Larsson SC, Gill D, Burgess S, et al
    Concerns about instrumental variable selection for biological effect versus uptake of proton pump inhibitors in Mendelian randomisation analysis.
    Gut. 2024 May 2:gutjnl-2024-332280. doi: 10.1136/gutjnl-2024-332280.
    PubMed    
    
    
    April 2024
17. DUTTA AK, Sharma V, Jain A, Elhence A, et al
    Inappropriate use of proton pump inhibitors in clinical practice globally: a systematic review and meta-analysis.
    Gut. 2024 Apr 26:gutjnl-2024-332154. doi: 10.1136/gutjnl-2024-332154.
    PubMed    
    
    
    March 2024
18. BOECKXSTAENS G, Elsen S, Belmans A, Annese V, et al
    10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy.
    Gut. 2024;73:582-589.
    PubMed     Abstract available
    
    
    February 2024
19. AN H, Zhong M, Gan H
    Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.
    Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904.
    PubMed    
    
    
    January 2024
20. XIAO X, Zhang X, Wang J, Liu Y, et al
    Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Gut. 2024 Jan 24:gutjnl-2023-330883. doi: 10.1136/gutjnl-2023-330883.
    PubMed    
    
    
    
21. BLACK CJ, Paine PA, Ford AC
    Letter to the editor: Helicobacter pylori eradication, the proof is not in the symptoms-authors' reply.
    Gut. 2024 Jan 12:gutjnl-2024-331892. doi: 10.1136/gutjnl-2024-331892.
    PubMed    
    
    
    December 2023
22. NARENDREN A, Tsoi AH, Iqbal A, Glance S, et al
    Rare complication of peptic ulcer disease.
    Gut. 2023 Dec 12:gutjnl-2023-330867. doi: 10.1136/gutjnl-2023-330867.
    PubMed    
    
    
    
23. TOH DE, Lo SW, Tsoi A, Segal JP, et al
    Right tool for the right bleeder.
    Gut. 2023;73:206-207.
    PubMed    
    
    
    November 2023
24. ZHU J, Sun C, Li M, Hu G, et al
    Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Gut. 2023 Nov 22:gutjnl-2023-330168. doi: 10.1136/gutjnl-2023-330168.
    PubMed     Abstract available
    
    
    
25. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    PubMed    
    
    
    September 2023
26. LIU BD, Udemba SC, Liang K, Tarabichi Y, et al
    Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort st
    Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651.
    PubMed     Abstract available
    
    
    July 2023
27. 
    Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259.
    PubMed     Abstract available
    
    
    June 2023
28. SJOMINA O, Vangravs R, Leonova E, Polaka I, et al
    Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
    Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792.
    PubMed    
    
    
    May 2023
29. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    PubMed    
    
    
    
30. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    PubMed     Abstract available
    
    
    April 2023
31. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available
    
    
    
32. YE BD
    Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
    Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506.
    PubMed    
    
    
    March 2023
33. CHEN PY, Tsai FP, Chen MJ, Yang HY, et al
    Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials.
    Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826.
    PubMed    
    
    
    
34. ZHANG J, Deng Y, Liu C, Wang H, et al
    'Family-based' strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat' strategy.
    Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696.
    PubMed    
    
    
    
35. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point.
    Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum